Financials

News Discussions Technicals Forecast Seasonals

818 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. operating, investing, and financing activities

818 free cash flow for H2 24 is -1.01 M EUR. For 2024, 818 free cash flow was -2.52 M EUR and operating cash flow was 23.27 M EUR.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—